PubMed:27184800 / 1705-1847 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":142},"obj":"Sentence"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-entities","denotations":[{"id":"11361","span":{"begin":29,"end":32},"obj":"GeneOrGeneProduct"},{"id":"11362","span":{"begin":92,"end":101},"obj":"ChemicalEntity"},{"id":"11363","span":{"begin":129,"end":135},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A38","pred":"db_id","subj":"11361","obj":"NCBIGene:4495"},{"id":"A39","pred":"db_id","subj":"11362","obj":"MESH:D000077157"},{"id":"A40","pred":"db_id","subj":"11363","obj":"MESH:D009369"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin_Mondo","denotations":[{"id":"T9","span":{"begin":129,"end":135},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0004992"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T42","span":{"begin":6,"end":14},"obj":"GeneOrGeneProduct"},{"id":"T43","span":{"begin":29,"end":32},"obj":"GeneOrGeneProduct"},{"id":"T44","span":{"begin":82,"end":88},"obj":"GeneOrGeneProduct"},{"id":"T45","span":{"begin":136,"end":141},"obj":"GeneOrGeneProduct"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T26","span":{"begin":29,"end":32},"obj":"GeneOrGeneProduct"},{"id":"T27","span":{"begin":82,"end":88},"obj":"GeneOrGeneProduct"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T21","span":{"begin":129,"end":135},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A21","pred":"originalLabel","subj":"T21","obj":"D009369"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T13","span":{"begin":29,"end":32},"obj":"GeneOrGeneProduct"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T21","span":{"begin":129,"end":135},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A21","pred":"ID:","subj":"T21","obj":"D009369"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T20","span":{"begin":129,"end":135},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A20","pred":"#label","subj":"T20","obj":"D009369"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T22","span":{"begin":92,"end":101},"obj":"ChemicalEntity"}],"attributes":[{"id":"A22","pred":"ID:","subj":"T22","obj":"D000077157"},{"id":"A23","pred":"ID:","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T22","span":{"begin":92,"end":101},"obj":"ChemicalEntity"},{"id":"T33532","span":{"begin":29,"end":32},"obj":"GeneOrGeneProduct"},{"id":"T98655","span":{"begin":129,"end":135},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A23","pred":"ID:","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"},{"id":"A22","pred":"ID:","subj":"T22","obj":"D000077157"},{"id":"A89623","pred":"#label","subj":"T98655","obj":"D009369"}],"text":"These findings indicate that MT1 constitute a biomarker adapted for exploring the impact of sorafenib on the redox metabolism of cancer cells."}